Literature DB >> 24078010

Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters.

Gener Ismail, Gabriel Mircescu, Alecse Valerian Ditoiu, Beatrice Dorina Tacu, Roxana Jurubita, Mihai Harza.   

Abstract

PURPOSE: The venous thromboembolic events (VTE) incidence is high in nephrotic syndrome (NS). We aimed to assess prospectively the risk of VTE in a large cohort of NS patients and to identify predictive factors for VTE, especially haemostasis-related parameters.
METHODS: This is the prospective, observational study conducted in 256 adults with idiopathic NS. VTE were the study outcome. Clinical data, proteinuria, albuminuria, haemostasis and fibrinolysis parameters, and D-dimers were evaluated every 6 months.
RESULTS: Median follow-up time was 24 [IQR 12–72] months. VTE cumulative and rate incidence were 11 % and 4.4 per 100 patient-years. Baseline higher proteinuria,lower serum albumin, low antithrombin III activity, and,surprisingly, high ionized calcium were VTE independent predictors. Proteinuria and serum albumin cut-offs, and positive and negative predictive values (PPV and NPV) for VTE were 9.0 g/24 h (30 % PPV and 90 % NPV) and 1.5 g/dL (69 % PPV and 93 % NPV).
CONCLUSIONS: The rate of VTE incidence of 4.4 per 100 patient-years found in this prospective study confirms the idiopathic nephrotic syndrome as a thromboembolism-generating condition. Severe and unremitting proteinuria and hypoalbuminemia,low antithrombin III activity, and, surprisingly, high ionized calcium are independent VTE predictors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24078010     DOI: 10.1007/s11255-013-0574-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  23 in total

1.  Blood levels of 25-hydroxyvitamin D in nephrotic syndrome. Studies in 26 patients.

Authors:  D A Goldstein; Y Oda; K Kurokawa; S G Massry
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

Review 2.  Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.

Authors:  F Llach
Journal:  Kidney Int       Date:  1985-09       Impact factor: 10.612

3.  Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome-a prospective study.

Authors:  Shi-Jun Li; Jing-Zhou Guo; Ke Zuo; Jiong Zhang; Yang Wu; Chang-sheng Zhou; Guang-ming Lu; Zhi-hong Liu
Journal:  Thromb Res       Date:  2012-05-26       Impact factor: 3.944

4.  The role of lung scintigraphy in the diagnosis of nephrotic syndrome with pulmonary embolism.

Authors:  S C Cherng; W S Huang; Y F Wang; S P Yang; Y F Lin
Journal:  Clin Nucl Med       Date:  2000-03       Impact factor: 7.794

5.  Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

Authors:  Paul M Ridker; Samuel Z Goldhaber; Ellie Danielson; Yves Rosenberg; Charles S Eby; Steven R Deitcher; Mary Cushman; Stephan Moll; Craig M Kessler; C Gregory Elliott; Rolf Paulson; Turnly Wong; Kenneth A Bauer; Bruce A Schwartz; Joseph P Miletich; Henri Bounameaux; Robert J Glynn
Journal:  N Engl J Med       Date:  2003-02-24       Impact factor: 91.245

6.  The clinical spectrum of renal vein thrombosis: acute and chronic.

Authors:  F Llach; S Papper; S G Massry
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

7.  Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy.

Authors:  F P Sarasin; J A Schifferli
Journal:  Kidney Int       Date:  1994-02       Impact factor: 10.612

8.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

Review 9.  D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review.

Authors:  Paul D Stein; Russell D Hull; Kalpesh C Patel; Ronald E Olson; William A Ghali; Rollin Brant; Rita K Biel; Vinay Bharadia; Neeraj K Kalra
Journal:  Ann Intern Med       Date:  2004-04-20       Impact factor: 25.391

10.  Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study.

Authors:  Sanjeev Kumar; Ananda Chapagain; Dorothea Nitsch; Muhammad M Yaqoob
Journal:  BMC Nephrol       Date:  2012-09-10       Impact factor: 2.388

View more
  7 in total

1.  Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Vivian S Gainer; Su-Chun Cheng; Tianxi Cai; Elizabeth Scoville; Gauree G Konijeti; Peter Szolovits; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-12       Impact factor: 11.382

Review 2.  The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio A Brito-Melo; Cayo Antônio Soares de Almeida; Lázaro Lopes Moreira; Cleiton Willian Cordeiro; Thiago Guimarães Rosa Carvalho; Elvis Cueva Mateo; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

3.  Nephrotic Syndrome Complications - New and Old. Part 1.

Authors:  Ruxandra Mihaela Busuioc; Gabriel Mircescu
Journal:  Maedica (Bucur)       Date:  2022-03

4.  Ischemic Stroke of Possible Embolic Etiology Associated With Nephrotic Syndrome.

Authors:  Claudie Roy; Yan Deschaintre; Ramsey Sabbagh; Daniel Roy; Héloïse Cardinal; Guillaume Bollée
Journal:  Kidney Int Rep       Date:  2017-04-21

5.  Inherited Risk Factors of Thromboembolic Events in Patients with Primary Nephrotic Syndrome.

Authors:  Gener Ismail; Bogdan Obrișcă; Roxana Jurubiță; Andreea Andronesi; Bogdan Sorohan; Mihai Hârza
Journal:  Medicina (Kaunas)       Date:  2020-05-19       Impact factor: 2.430

6.  Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications.

Authors:  Sarah Kelddal; Karen Marie Nykjær; Jon Waarst Gregersen; Henrik Birn
Journal:  BMC Nephrol       Date:  2019-04-25       Impact factor: 2.388

7.  A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome.

Authors:  Raymond Lin; Georgina McDonald; Todd Jolly; Aidan Batten; Bobby Chacko
Journal:  Kidney Int Rep       Date:  2019-12-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.